Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Description | Gaviscon Advance oral suspension peppermint (Reckitt Benckiser Healthcare (UK) Ltd) |
| BNF code | 0101021B0BEBEAL |
| Virtual Medicinal Product | Sodium alginate 500mg/5ml / Potassium bicarbonate 100mg/5ml oral suspension sugar free |
| Name | Gaviscon Advance oral suspension peppermint |
| Date of name applicability | 25 Apr 2006 |
| Previous name | Gaviscon Advance liquid peppermint |
| Supplier | Reckitt Benckiser Healthcare (UK) Ltd |
| Current licensing authority | Medicines - MHRA/EMA |
| Flavour | Peppermint |
| EMA additional monitoring | ✗ |
| Parallel import | ✗ |
| Restrictions on availability | None |
| Licensed Route | |
|---|---|
| Licenced route | Oral |
| Actual Medicinal Product Packs | |
| Gaviscon Advance oral suspension peppermint (Reckitt Benckiser Healthcare (UK) Ltd) 250 ml | |
| Gaviscon Advance oral suspension peppermint (Reckitt Benckiser Healthcare (UK) Ltd) 300 ml | |
| Gaviscon Advance oral suspension peppermint (Reckitt Benckiser Healthcare (UK) Ltd) 500 ml | |
dm+d data retrieved from TRUD: release NHSBSA_11.2.0_20241118000001, imported on 19th November 2024 at 03:53:26.